Bottom line is this, we have 3, 6, 9 months max until we get the final verdict. If within this duration they decide to tweak again, delay, etc it's over for them. Pretty much everyone is at there whits end. Most will sell and they won't be able to raise enough cash at .50 to survive the new delay. If this past month or two has not clued them in on this then they deserve insolvency.
I do not include one more potential dilution raise as the nail in the coffin AS LONG as they remain on track. I personally believe we will get a nice chunk from the 3.20's to avoid another dilution raise. However, let's say they do another raise in Jan/Feb the pain will be short lived as design freeze, CE Mark, FDA, etc, etc would only be a couple months away at that point in time. The $2 levels will be long gone by then
The silence and not supporting this raise and R/S has been very disappointing. I'm giving Mc a mulligan on this one. The Nov delay was at the urging of Estape and other SAB members. Not pinning that one on Mc. As far he knew at that point they were still on track.
Just remember, were basically in September. A few more months and its 2019, which means game on. It will be nice to say design freeze this year, CE Mark this year, FDA this year will be cutting it close, but you get the point.
NO MORE DAMN DELAYS, then were looking really good. I'd rather have a game/market changing product and have to deal with some financing, PR flubs, then a crap product and a flawless to market execution.
GLTA
News 
Market Data 
Discover 
AI
